REGULATORY INSPECTIONS definition

REGULATORY INSPECTIONS means an inspection by any Regulatory Authority of the Facility or of Chesapeake's processes and/or equipment used in Manufacture or in the storage of Finished Products, or any part or component thereof;
Sample 1

Examples of REGULATORY INSPECTIONS in a sentence

  • AND NON-CONFORMANCE 10 Article 12 REFERENCE AND RETENTION SAMPLES 12 Article 13 STORAGE OF PRODUCT / ENVIRONMENTAL MONITORING 12 Article 14 COMPLAINTS 13 Article 15 CHANGE CONTROL 13 Article 16 REPROCESSING AND REWORK 14 Article 17 SUB-CONTRACTING 14 Article 18 REGULATORY INSPECTIONS 14 Article 19 PERIODIC QUALITY REVIEWS 15 Article 20 ON-GOING GMP STABILITY 15 Article 21 ANNUAL REPORT 15 * Confidential treatment requested.

  • REGULATORY INSPECTIONS A regulatory inspection is generally conducted a minimum of three times per year at each licensed establishment to ensure that a licensee is compliant with alcoholic beverage laws.

  • Quality assurance 7.5 ASSESSMENT SYSTEM AND REGULATORY INSPECTIONS The role of the Commission consists in reviewing that the design, construction and operation criteria are in accordance with its own codes and regulations and those adopted from the nuclear industry.

  • Program Evaluation Title V Inspections Proportion of Inspection Types AMD Performance/ Impact Reclamation Success/Impact REGULATORY INSPECTIONS Performance/Off-site impact - Randomly selected active and inactive sites.

  • JOHSC FORMAL RECOMMENDATION LETTERS & REGULATORY INSPECTIONS (e.g., WorkSafeBC) competing priorities and may not physically be capable of shovelling snow.Gerald will aim to reach out to all JOHSC co-chairs at UBC and determine if there is interest in sending a joint formal recommendation letter to the employer.

  • JOHSC FORMAL RECOMMENDATION LETTERS & REGULATORY INSPECTIONS (e.g. WorkSafeBC)Item #(use Recommendation or Report #)PriorityDiscussion and/or Action ItemsAssigned ToDate of IssueDate to be CompletedStatusNothing to report.

  • JOHSC FORMAL RECOMMENDATION LETTERS & REGULATORY INSPECTIONS (e.g., WorkSafeBC) Overall accessibility pathways are still not being cleared.

  • JOHSC FORMAL RECOMMENDATION LETTERS & REGULATORY INSPECTIONS (e.g. WorkSafeBC)Item #(use Recommendationor Report #)PriorityDiscussion and/or Action ItemsAssigned ToDate of IssueDate to be CompletedStatusThere is no correspondence at this time.

  • In areas where there is still a good size prospective workforce, farmers are having problems procuring seeds and pesticides to protect their crops from stalk borers which, along with the sporadic rainfall in such areas, are giving local farmers a good reason to give up farming altogether.

  • JOHSC FORMAL RECOMMENDATION LETTERS & REGULATORY INSPECTIONS (e.g. WorkSafeBC)Item #(use Recommendation orReport #)PriorityDiscussion and/or Action ItemsAssigned ToDate of IssueDate to be CompletedStatusIR202216973025AEViolence Risk Assessment required at the Centre for Gender & Sexual Health Equity.Investigation submitted and received: no further action required of the JOHSCN/A2022/03/02N/ACIR202217748019AEWorker contacted WSBC to enquire about the viability of ductless fume hoods.

Related to REGULATORY INSPECTIONS

  • Regulatory Information Service means a regulatory information service as defined in the FCA Handbook;

  • Studies means activities needed to prepare project implementation, such as preparatory, mapping, feasibility, evaluation, testing and validation studies, including in the form of software, and any other technical support measure, including prior action to define and develop a project and decide on its financing, such as reconnaissance of the sites concerned and preparation of the financial package;

  • Inspections has the meaning set forth in Section 4.1.2.

  • Clinical Studies means any clinical studies of a Licensed Product conducted on humans.

  • Regulatory Agencies The Office of the Comptroller of the Currency; the Board of Governors of the Federal Reserve System; the Federal Deposit Insurance Corporation; the Federal Housing Finance Agency; the Securities and Exchange Commission; and the Department of Housing and Urban Development.

  • Adverse Event means any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and that does not necessarily have a causal relationship with the treatment. An adverse event can therefore be any unfavourable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal product, whether or not related to the medicinal product.

  • Regulatory Bodies means those government departments and regulatory, statutory and other entities, committees, ombudsmen and bodies which, whether under statute, rules, regulations, codes of practice or otherwise, are entitled to regulate, investigate, or influence the matters dealt with in the Contract or any other affairs of the Authority and “Regulatory Body” shall be construed accordingly.

  • Updates are changes that do not require a change to the established Centralized Contract terms and conditions. A request to add new products at the same or better price level is an example of an update. “Amendments” are any changes that are not specifically covered by the terms and conditions of the Centralized Contract, but inclusion is found to be in the best interest of the State. A request to change a contractual term and condition is an example of an amendment.

  • Regulatory Materials means materials developed or compiled in preparation for Regulatory Authority meetings, regulatory applications, submissions, dossiers, notifications, registrations, Regulatory Approvals and/or other filings made to or with, or other approvals granted by, a Regulatory Authority that are necessary or reasonably desirable for the Development, manufacture, market, sale, or Commercialization of a Licensed Product in a particular regulatory jurisdiction.

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Regulatory Data means any and all research data, pharmacology data, chemistry, manufacturing and control data, preclinical data, clinical data and all other documentation submitted, or required to be submitted, to Regulatory Authorities in association with regulatory filings for the Product (including any applicable Drug Master Files (“DMFs”), Chemistry, Manufacturing and Control (“CMC”) data, or similar documentation).

  • Regulatory Authorities means the Commissions and the Exchange;

  • Protocols means written directions and orders, consistent with the department’s standard of care, that are to be followed by an emergency medical care provider in emergency and nonemergency situations. Protocols must be approved by the service program’s medical director and address the care of both adult and pediatric patients.

  • Facilities Study shall be an engineering study conducted by the Transmission Provider (in coordination with the affected Transmission Owner(s)) to: (1) determine the required modifications to the Transmission Provider’s Transmission System necessary to implement the conclusions of the System Impact Study; and (2) complete any additional studies or analyses documented in the System Impact Study or required by PJM Manuals, and determine the required modifications to the Transmission Provider’s Transmission System based on the conclusions of such additional studies. The Facilities Study shall include the cost and scheduled completion date for such modifications, that will be required to provide the requested transmission service or to accommodate a New Service Request. As used in the Interconnection Service Agreement or Construction Service Agreement, Facilities Study shall mean that certain Facilities Study conducted by Transmission Provider (or at its direction) to determine the design and specification of the Customer Funded Upgrades necessary to accommodate the New Service Customer’s New Service Request in accordance with Tariff, Part VI, section 207. Federal Power Act:

  • Final Inspection means the process and procedure described in UGC Section 12.1.

  • Study Data shall have the meaning set forth in Section 8.1.

  • competent authorities means the competent authorities of the Member States as identified on the websites listed in Annex II;

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Regulatory Services Provider means the organization which provides regulatory services to BSEF pursuant to a Regulatory Services Agreement.